MarketInOut Stock Screener Log In | Sign Up

Appili Therapeutics Inc

OTC • Healthcare • Biotechnology • Quote as of 11/17/2026 15:46
Appili Therapeutics Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeOTC
Market Capitalization0.2647 mln
Float118 mln
Earnings Date11/13/2026

Piotroski F-Score

4 / 9
Borderline

Relative Strength

1 / 100
Severely lagging

Pre-Tax Margin

-1,838%
Severely loss-making

Altman Z-Score

-92.3
Deeply distressed

ROA

-447
Deeply negative

Business Description

Appili Therapeutics is a Canadian company focused on finding and developing new treatments for infectious diseases that currently lack effective solutions. Their pipeline includes three key products: a child-friendly liquid form of the antibiotic metronidazole, a topical skin treatment for a parasitic disease called cutaneous leishmaniasis, and a vaccine targeting a rare but serious bacterial infection known as tularensis. Founded in 2015 and based in Halifax, the company works to address critical gaps in how infectious diseases are treated today.

Key Fundamentals

EPS-0.03
ROIC-49.68
ROA-447
EBITDA, mln-2.98
EV / EBITDA-3.36
EV / EBIT-3.35
Revenue, mln0.22
EV / Revenue46.63

Quote Details

Last 0.001
Change -0.001 (-50%)
Open 0.001
Volume 15,207
Turnover 15.21
Average Volume 26,541

Financial Ratios

Pre-Tax Profit Margin-1,838
Current Ratio0.07
Price / Sales2.50

Financial Strength

Altman Z-Score-92.3
Piotroski F-Score 4 / 9

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -84.85% 1 / 100   
1 Month -91.15% 1 / 100   
2 Months -94.44% 1 / 100   
6 Months -90.29% 3 / 100   
1 Year -96.15% 4 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog